Gene analysis, treatment, and follow-up of sixteen Chinese patients with Bartter syndrome
10.3760/cma.j.issn.1001-7097.2017.08.003
- VernacularTitle:中国16例巴特综合征基因突变分析和治疗随访研究
- Author:
Yue HAN
;
Yi LIN
;
Qing SUN
;
Shujuan WANG
;
Yanxia GAO
;
Leping SHAO
- Keywords:
Bartter syndrome;
Mutation;
CLCNKB gene;
SLC12A1 gene;
BSND gene;
Genotype and phenotype
- From:
Chinese Journal of Nephrology
2017;33(8):573-581
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the mutations of causal genes in sixteen Chinese patients with suspicious Bartter syndrome,and follow up their treatment results.Methods Mutations were identified by the next generation sequencing and the multiplex ligation-dependent probe amplification (MLPA).Clinical and biochemical features at the first presentation as well as follow-up results were reviewed.Results 15 different CLCNKB gene mutations were identified in sixteen patients with BS,including 11 novel ones.A novel missense mutation and a novel small deletion were found from SLC12A1 gene.A novel gross deletion was found in CLCNKA gene.A recurrent missense mutation was identified from BSND gene.The whole gene deletion mutation of CLCNKB gene was the most frequent mutation (32％),and the rate of gross deletion was up to 50 percent in this group of Chinese patients.The most common clinical manifestations were development retardation (15/16),polydipsia and polyuria (15/16).All of the patients were detected with hypokalemia,hypochloremia and metabolic alkalosis.Indomethacin treatment had significant improvement to the stature and weight restoration.Conclusion The present study has found 19 mutations,including 14 novel ones,which enriches the human gene mutation database (HGMD) and provides valuable references to the genetic counseling and diagnosis of Chinese population.
